← SynDRA
Y-26763
SynDRA canonical compound SYN1952628 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | KCNJ8 |
|---|
| Mechanism of action | potassium channel activator |
|---|
All known targets
Mechanisms of action (all sources)
- potassium channel activator
Cross-references
Look up Y-26763 in the interactive SynDRA portal →